Patrice Hildgen - Publications

Affiliations: 
Université de Montréal, Montréal, Canada 
Area:
Biomedical Engineering

59 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Tehrani SF, Rabanel JM, Legeay S, Cayon J, Riou J, Saulnier P, Marleau S, Gaëlle Roullin V, Hildgen P, Bastiat G. Tailoring PEGylated nanoparticle surface modulates inflammatory response in vascular endothelial cells. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V. PMID 35413403 DOI: 10.1016/j.ejpb.2022.04.003  0.35
2019 Latreille PL, Adibnia V, Nour A, Rabanel JM, Lalloz A, Arlt J, Poon WCK, Hildgen P, Martinez VA, Banquy X. Spontaneous shrinking of soft nanoparticles boosts their diffusion in confined media. Nature Communications. 10: 4294. PMID 31541104 DOI: 10.1038/S41467-019-12246-X  0.382
2019 Derbali RM, Aoun V, Moussa G, Frei G, F Tehrani S, Campos Del'Orto J, Hildgen P, Roullin VG, Leblond Chain J. Tailored nanocarriers for the pulmonary delivery of levofloxacin against Pseudomonas aeruginosa: a comparative study. Molecular Pharmaceutics. PMID 30900903 DOI: 10.1021/Acs.Molpharmaceut.8B01256  0.364
2019 Lalloz A, Bolzinger MA, Briançon S, Faivre J, Rabanel JM, Garcia Ac A, Hildgen P, Banquy X. Subtle and unexpected role of PEG in tuning the penetration mechanisms of PLA-based nano-formulations into intact and impaired skin. International Journal of Pharmaceutics. PMID 30825557 DOI: 10.1016/J.Ijpharm.2019.02.039  0.424
2019 Rabanel JM, Adibnia V, Tehrani SF, Sanche S, Hildgen P, Banquy X, Ramassamy C. Nanoparticle heterogeneity: an emerging structural parameter influencing particle fate in biological media? Nanoscale. 11: 383-406. PMID 30560970 DOI: 10.1039/C8Nr04916E  0.338
2018 Tehrani SF, Bernard-Patrzynski F, Puscas I, Leclair G, Hildgen P, Roullin VG. Length of surface PEG modulates nanocarrier transcytosis across brain vascular endothelial cells. Nanomedicine : Nanotechnology, Biology, and Medicine. PMID 30582996 DOI: 10.1016/J.Nano.2018.11.016  0.663
2018 Elkin I, Maris T, Hildgen P, Barrett CJ. Crystal structures of the solvent-free and ethanol disolvate forms of 4,4'-(diazenediyl)bis(2,3,5,6-tetrafluorobenzoic acid) exemplifying self-stabilized azo-benzene -configurations. Acta Crystallographica. Section E, Crystallographic Communications. 74: 1486-1490. PMID 30319807 DOI: 10.1107/S2056989018012781  0.704
2018 Lalloz A, Bolzinger MA, Faivre J, Latreille PL, Garcia Ac A, Rakotovao C, Rabanel JM, Hildgen P, Banquy X, Briançon S. Effect of Surface Chemistry of Polymeric Nanoparticles on Cutaneous Penetration of Cholecalciferol. International Journal of Pharmaceutics. PMID 30316003 DOI: 10.1016/J.Ijpharm.2018.09.046  0.47
2018 Elkin I, Maris T, Melkoumov A, Hildgen P, Banquy X, Leclair G, Barrett C. Crystal structure of 2-oxopyrrolidin-3-yl 4-(2-phenyl-diazen-1-yl)benzoate. Acta Crystallographica. Section E, Crystallographic Communications. 74: 458-460. PMID 29765745 DOI: 10.1107/S205698901800333X  0.738
2018 Rode Garcia T, Garcia Ac A, Lalloz A, Lacasse FX, Hildgen P, Rabanel JM, Banquy X. Unified scaling of the structure and loading of nanoparticles formed via diffusion-limited coalescence. Langmuir : the Acs Journal of Surfaces and Colloids. PMID 29708345 DOI: 10.1021/Acs.Langmuir.8B00652  0.423
2018 Mokhtar M, Gosselin PM, François-Xavier L, Hildgen P. Tablet Formulation of Famotidine loaded P-gp inhibiting Nanoparticles using PLA-g-PEG Grafted Polymer. Pharmaceutical Development and Technology. 1-49. PMID 29564944 DOI: 10.1080/10837450.2018.1455695  0.483
2017 Elkin I, Banquy X, Barrett CJ, Hildgen P. Non-covalent formulation of active principles with dendrimers: Current state-of-the-art and prospects for further development. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 28887136 DOI: 10.1016/J.Jconrel.2017.09.002  0.741
2017 Elkin I, Maris T, Hildgen P. Synthesis and characterization of 3-methyl-6-[(propyn-yloxy)meth-yl]-1,4-dioxane-2,5-dione. Acta Crystallographica. Section E, Crystallographic Communications. 73: 1044-1047. PMID 28775879 DOI: 10.1107/S2056989017008581  0.701
2017 Mokhtar M, Gosselin PM, Lacasse F, Hildgen P. Design of PEG-grafted-PLA nanoparticles as oral permeability enhancer for P-gp substrate drug model Famotidine. Journal of Microencapsulation. 1-51. PMID 28151040 DOI: 10.1080/02652048.2017.1290155  0.447
2017 Pound-Lana G, Rabanel J, Hildgen P, Mosqueira VCF. Functional polylactide via ring-opening copolymerisation with allyl, benzyl and propargyl glycidyl ethers European Polymer Journal. 90: 344-353. DOI: 10.1016/J.Eurpolymj.2017.03.028  0.34
2015 Rabanel JM, Faivre J, Paka GD, Ramassamy C, Hildgen P, Banquy X. Effect of polymer architecture on curcumin encapsulation and release from PEGylated polymer nanoparticles: Toward a drug delivery nano-platform to the CNS. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft FüR Pharmazeutische Verfahrenstechnik E.V. 96: 409-20. PMID 26409200 DOI: 10.1016/J.Ejpb.2015.09.004  0.488
2015 Rabanel JM, Faivre J, Tehrani SF, Lalloz A, Hildgen P, Banquy X. Effect of the Polymer Architecture on the Structural and Biophysical Properties of PEG-PLA Nanoparticles. Acs Applied Materials & Interfaces. 7: 10374-85. PMID 25909493 DOI: 10.1021/Acsami.5B01423  0.455
2015 Elkin I, Rabanel JM, Hildgen P. Influence of Hydrophobic Dendrimer Core Structure on the Itraconazole Encapsulation Efficiency Macromolecular Chemistry and Physics. DOI: 10.1002/Macp.201500211  0.747
2015 Elkin I, Rabanel JM, Aoun V, Hildgen P. Synthesis and evaluation of symmetrically PEG-decorated triglycerides of fatty acid as drug-encapsulating agents Macromolecular Chemistry and Physics. 216: 427-438. DOI: 10.1002/Macp.201400486  0.753
2014 Rabanel JM, Hildgen P, Banquy X. Assessment of PEG on polymeric particles surface, a key step in drug carrier translation. Journal of Controlled Release : Official Journal of the Controlled Release Society. 185: 71-87. PMID 24768790 DOI: 10.1016/J.Jconrel.2014.04.017  0.429
2014 Elkin I, Hildgen P. Convenient synthesis of a polyester-co-polyether block for assembling biocompatible hyperbranched macromolecules Macromolecular Chemistry and Physics. 215: 177-181. DOI: 10.1002/Macp.201300578  0.699
2013 Daheb K, Lipman ML, Hildgen P, Roy JJ. Artificial neural network modeling for drug dialyzability prediction. Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society For Pharmaceutical Sciences, SociéTé Canadienne Des Sciences Pharmaceutiques. 16: 665-75. PMID 24393550 DOI: 10.18433/J35C8B  0.306
2013 Le Dévédec F, Strandman S, Hildgen P, Leclair G, Zhu XX. PEGylated bile acids for use in drug delivery systems: enhanced solubility and bioavailability of itraconazole. Molecular Pharmaceutics. 10: 3057-66. PMID 23837910 DOI: 10.1021/Mp400117M  0.695
2013 Essa S, Louhichi F, Raymond M, Hildgen P. Improved antifungal activity of itraconazole-loaded PEG/PLA nanoparticles. Journal of Microencapsulation. 30: 205-17. PMID 22894166 DOI: 10.3109/02652048.2012.714410  0.796
2013 Elkin I, Hildgen P. Selective synthesis of glyceryl tris[9,10-(threo)-dihydroxyoctadecanoate] Jaocs, Journal of the American Oil Chemists' Society. 90: 1465-1474. DOI: 10.1007/S11746-013-2295-Z  0.707
2012 Rabanel JM, Aoun V, Elkin I, Mokhtar M, Hildgen P. Drug-loaded nanocarriers: passive targeting and crossing of biological barriers. Current Medicinal Chemistry. 19: 3070-102. PMID 22612696 DOI: 10.2174/092986712800784702  0.744
2011 Melkoumov A, Soukrati A, Elkin I, Forest JM, Hildgen P, Leclair G. Quality evaluation of extemporaneous delayed-release liquid formulations of lansoprazole. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. 68: 2069-74. PMID 22011986 DOI: 10.2146/Ajhp100634  0.741
2011 Essa S, Rabanel JM, Hildgen P. Characterization of rhodamine loaded PEG-g-PLA nanoparticles (NPs): effect of poly(ethylene glycol) grafting density. International Journal of Pharmaceutics. 411: 178-87. PMID 21458551 DOI: 10.1016/J.Ijpharm.2011.02.039  0.792
2010 Essa S, Rabanel JM, Hildgen P. Effect of polyethylene glycol (PEG) chain organization on the physicochemical properties of poly(D, L-lactide) (PLA) based nanoparticles. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft FüR Pharmazeutische Verfahrenstechnik E.V. 75: 96-106. PMID 20211727 DOI: 10.1016/J.Ejpb.2010.03.002  0.796
2010 Essa S, Rabanel JM, Hildgen P. Effect of aqueous solubility of grafted moiety on the physicochemical properties of poly(d,l-lactide) (PLA) based nanoparticles. International Journal of Pharmaceutics. 388: 263-73. PMID 20060450 DOI: 10.1016/J.Ijpharm.2009.12.059  0.793
2010 Elkin I, Hildgen P. Simulation of itraconazole encapsulation by novel biocampatible dendritic compounds Macromolecular Symposia. 297: 154-157. DOI: 10.1002/Masy.200900078  0.735
2009 Rabanel JM, Banquy X, Zouaoui H, Mokhtar M, Hildgen P. Progress technology in microencapsulation methods for cell therapy. Biotechnology Progress. 25: 946-63. PMID 19551901 DOI: 10.1002/Btpr.226  0.337
2009 Hammady T, Rabanel JM, Dhanikula RS, Leclair G, Hildgen P. Functionalized nanospheres loaded with anti-angiogenic drugs: cellular uptake and angiosuppressive efficacy. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft FüR Pharmazeutische Verfahrenstechnik E.V. 72: 418-27. PMID 19462478 DOI: 10.1016/J.Ejpb.2009.01.007  0.786
2009 Dhanikula RS, Hammady T, Hildgen P. On the mechanism and dynamics of uptake and permeation of polyether-copolyester dendrimers across an in vitro blood-brain barrier model. Journal of Pharmaceutical Sciences. 98: 3748-60. PMID 19156840 DOI: 10.1002/Jps.21669  0.759
2009 Hammady T, El-Gindy A, Lejmi E, Dhanikula RS, Moreau P, Hildgen P. Characteristics and properties of nanospheres co-loaded with lipophilic and hydrophilic drug models. International Journal of Pharmaceutics. 369: 185-95. PMID 19071201 DOI: 10.1016/J.Ijpharm.2008.10.034  0.781
2009 Banquy X, Suarez F, Argaw A, Rabanel JM, Grutter P, Bouchard JF, Hildgen P, Giasson S. Effect of mechanical properties of hydrogel nanoparticles on macrophage cell uptake Soft Matter. 5: 3984-3991. DOI: 10.1039/B821583A  0.416
2008 Banquy X, Leclair G, Rabanel JM, Argaw A, Bouchard JF, Hildgen P, Giasson S. Selectins ligand decorated drug carriers for activated endothelial cell targeting. Bioconjugate Chemistry. 19: 2030-9. PMID 18803413 DOI: 10.1021/Bc800257M  0.675
2008 Sant S, Poulin S, Hildgen P. Effect of polymer architecture on surface properties, plasma protein adsorption, and cellular interactions of pegylated nanoparticles. Journal of Biomedical Materials Research. Part A. 87: 885-95. PMID 18228249 DOI: 10.1002/Jbm.A.31800  0.455
2008 Dhanikula RS, Argaw A, Bouchard JF, Hildgen P. Methotrexate loaded polyether-copolyester dendrimers for the treatment of gliomas: enhanced efficacy and intratumoral transport capability. Molecular Pharmaceutics. 5: 105-16. PMID 18171013 DOI: 10.1021/Mp700086J  0.357
2008 Sant S, Thommes M, Hildgen P. Microporous structure and drug release kinetics of polymeric nanoparticles. Langmuir : the Acs Journal of Surfaces and Colloids. 24: 280-7. PMID 18052222 DOI: 10.1021/La702244W  0.508
2007 Bertrand N, Leclair G, Hildgen P. Modeling drug release from bioerodible microspheres using a cellular automaton. International Journal of Pharmaceutics. 343: 196-207. PMID 17616285 DOI: 10.1016/J.Ijpharm.2007.05.050  0.688
2007 Dhanikula RS, Hildgen P. Influence of molecular architecture of polyether-co-polyester dendrimers on the encapsulation and release of methotrexate. Biomaterials. 28: 3140-52. PMID 17428531 DOI: 10.1016/J.Biomaterials.2007.03.012  0.404
2006 Rizkalla N, Range C, Lacasse FX, Hildgen P. Effect of various formulation parameters on the properties of polymeric nanoparticles prepared by multiple emulsion method. Journal of Microencapsulation. 23: 39-57. PMID 16830976 DOI: 10.1080/02652040500286185  0.481
2006 Dhanikula RS, Hildgen P. Synthesis and evaluation of novel dendrimers with a hydrophilic interior as nanocarriers for drug delivery. Bioconjugate Chemistry. 17: 29-41. PMID 16417249 DOI: 10.1021/Bc050184C  0.428
2006 Hammady T, Nadeau V, Hildgen P. Microemulsion and diafiltration approaches: an attempt to maximize the global yield of DNA-loaded nanospheres. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft FüR Pharmazeutische Verfahrenstechnik E.V. 62: 143-54. PMID 16288856 DOI: 10.1016/J.Ejpb.2005.08.011  0.757
2006 Nadeau V, Rabanel J, Sant S, Chahwan R, Clas S, Hildgen P. Synthesis and characterization of biodegradable and charged salen-based polymers Journal of Applied Polymer Science. 102: 2568-2577. DOI: 10.1002/App.24686  0.327
2005 Nadeau V, Hildgen P. AFM study of a new carrier based on PLA and salen copolymers for gene therapy. Molecules (Basel, Switzerland). 10: 105-13. PMID 18007280 DOI: 10.3390/10010105  0.314
2005 Quesnel R, Hildgen P. Synthesis of PLA-b-PEG multiblock copolymers for stealth drug carrier preparation. Molecules (Basel, Switzerland). 10: 98-104. PMID 18007279 DOI: 10.3390/10010098  0.41
2005 Rizkalla N, Hildgen P. Artificial neural networks: comparison of two programs for modeling a process of nanoparticle preparation. Drug Development and Industrial Pharmacy. 31: 1019-33. PMID 16316858 DOI: 10.1080/03639040500306294  0.315
2005 Sant S, Nadeau V, Hildgen P. Effect of porosity on the release kinetics of propafenone-loaded PEG-g-PLA nanoparticles. Journal of Controlled Release : Official Journal of the Controlled Release Society. 107: 203-14. PMID 16099525 DOI: 10.1016/J.Jconrel.2005.02.017  0.509
2005 Rabanel JM, Hildgen P. Preparation of hydrogel hollow particles for cell encapsulation by a method of polyester core degradation. Journal of Microencapsulation. 21: 413-31. PMID 15513748 DOI: 10.1080/02652040410001729223  0.306
2005 Nadeau V, Leclair G, Sant S, Rabanel JM, Quesnel R, Hildgen P. Synthesis of new versatile functionalized polyesters for biomedical applications Polymer. 46: 11263-11272. DOI: 10.1016/J.Polymer.2005.09.079  0.673
2003 Panoyan A, Quesnel R, Hildgen P. Injectable nanospheres from a novel multiblock copolymer: cytocompatibility, degradation and in vitro release studies. Journal of Microencapsulation. 20: 745-58. PMID 14594663 DOI: 10.1080/02652040310001599760  0.442
2003 Lemaire V, Bélair J, Hildgen P. Structural modeling of drug release from biodegradable porous matrices based on a combined diffusion/erosion process. International Journal of Pharmaceutics. 258: 95-107. PMID 12753757 DOI: 10.1016/S0378-5173(03)00165-0  0.364
2002 Ruel-Gariépy E, Leclair G, Hildgen P, Gupta A, Leroux JC. Thermosensitive chitosan-based hydrogel containing liposomes for the delivery of hydrophilic molecules. Journal of Controlled Release : Official Journal of the Controlled Release Society. 82: 373-83. PMID 12175750 DOI: 10.1016/S0168-3659(02)00146-3  0.678
1998 Buczkowski S, Hildgen P, Cartilier L. Comparison of Three Models of Polymer Erosion — in vivo, in vitro and Computer Simulation — Using Fractal Analysis Fractals. 6: 171-179. DOI: 10.1142/S0218348X98000213  0.301
1998 Lacasse F, Hildgen P, McMullen J. Surface and morphology of spray-dried pegylated PLA microspheres International Journal of Pharmaceutics. 174: 101-109. DOI: 10.1016/S0378-5173(98)00254-3  0.338
1997 Lacasse FX, Hildgen P, Pérodin J, Escher E, Phillips NC, McMullen JN. Improved activity of a new angiotensin receptor antagonist by an injectable spray-dried polymer microsphere preparation. Pharmaceutical Research. 14: 887-91. PMID 9244145 DOI: 10.1023/A:1012147700014  0.393
1995 Hildgen P, McMullen J. A new gradient matrix: Formulation and characterization Journal of Controlled Release. 34: 263-271. DOI: 10.1016/0168-3659(95)00014-Y  0.346
Show low-probability matches.